BioCentury
ARTICLE | Clinical News

Lenoxin data

May 2, 1994 7:00 AM UTC

The New York company announced results of a Phase III trial in 740 patients, showing that itching and swelling due to GPC resolved almost completely in three weeks, as compared to months with available treatments for this contact lens-associated problem. ...